NCT06524570 2026-02-18
iFOCUS
UMC Utrecht
Phase 1 Recruiting
Clinical Trials
8 trialsNCT07142200 2025-08-26
DECIDING
RenJi Hospital
Phase 2 Not yet recruiting
NCT03868046 2025-04-01
AUTENTIC
Hospital Universitario Araba
Completed
NCT05934214 2024-03-05
EXIT
Groupe Hospitalier Pitie-Salpetriere
Completed
NCT06047860 2023-09-21
A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer
Second Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT05790447 2023-03-30
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors
Second Affiliated Hospital of Soochow University
Phase 2 Unknown
NCT05322187 2022-04-11
sPLENTY-pc
RenJi Hospital
Phase 2/3 Unknown
NCT03492242 2019-09-26
CHIMeRA
Groupe Hospitalier Pitie-Salpetriere
Completed